Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Cannabidiol Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Cannabidiol Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Cannabidiol Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Cannabidiol Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 27 Jun 2021
  • Report ID: HLT 00228
  • Pages: 180
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

According to a study published by Insure Insights, the global cannabidiol market is expected to grow at a CAGR of 24.5% during the forecast period. Cannabidiol is generally used for seizure disorder (epilepsy). It is also used for the treatment of anxiety, pain, a muscle disorder called dystonia, Parkinson disease, Crohn disease, and many other conditions. Cannabidiol has effects on the brain. It prevents the breakdown of a chemical in the brain that affects pain, mood, and mental function. Minimizing the breakdown of this chemical and increasing its blood levels helps to reduce psychotic symptoms associated with conditions such as schizophrenia. CBD has been proven to modify circuits in the brain related to drug addiction.

Top Driver: Growing Acceptance and Legalization of Cannabis Across Numerous Countries

Growing acceptance and legalization of cannabis across numerous countries such as Colombia, Australia, Chile, Germany, France, and Spain have highly propelled the global cannabidiol market. Countries are abundantly using CBD for the treatment of diseases such as chronic pain, cancer, multiple sclerosis, and depression. Moreover, as the FDA has allowed commercializing CBD oil, several companies have begun to sell these oils on various e-commerce sites and in retail stores. Countries that have decriminalized the use of cannabis are encountering a progression in the economy. As a result, more and more countries are spending in the cannabis industry.

B2C Segment Accounts for the Largest Market Share

The cannabidiol market is segmented into Business to Consumer (B2C) and Business to Business (B2B) based on the distribution channel. The B2C segment includes hospital pharmacies, online stores, and retail pharmacies. The B2C segment accounted for the highest revenue share and is expected to grow at a significant rate over the forecast period. The easy availability of these products to the consumers is one of the major factors driving the growth of this segment. In addition to this, increased acceptance of CBD oil and tinctures for personal and medical use available through pharmacies, retail stores, and online stores is expected to drive the growth of this segment during the forecast period. Based on the Source, the market is segmented into hemp and marijuana. Based on the end-use, the market is segmented into medical, personal use, pharmaceuticals, and others.

  Increasing Decriminalization of Medical Cannabis to Benefit North America Market

North America accounted for the largest market share and will continue to the trend in the forecast period. The increasing decriminalization of medical cannabis in independent states of the U.S., the liberalism of government regulations concerning the same, and an overall increase in the adoption of cannabidiol for pharmaceutical, personal use, and wellness are some of the major factors driving the growth of the region.

Players to Focus on Collaboration and Expanding Product Portfolio

The major player operating in the global cannabidiol market are Isodiol, Medical Marijuana Inc., CV Sciences, Aurora Cannabis, Canopy Growth Corporation, NuLeaf Naturals, Tilray, Green Roads, GW Pharmaceuticals, Folium Biosciences, Medterra, Charlotte’s Web – CW Hemp, Endoca, Elixinol and Gaia Herbs, LLC.

Isodiol: In October 2019, Isodiol reported that it has entered into a strategic partnership with Vitamin Shoppe for the commercial release of Iso-Sport Products. This partnership was focused at expanding its cannabidiol hemp extract product portfolio for meeting the increasing customer demand.

CV Sciences: In November 2019, CV Sciences reported a new partnership with Southeastern Grocers to launch cannabidiol oil Plus brand that compromise topical as well as dietary products. The objective for the partnership was to increase availability and distribution of company’s best-selling PlusCBD oil products.

Scope of the Report

By Source Type

  • Hemp
  • Marijuana

By Distribution Channel

  • B2C
  • B2B

By End-User

  • Medical
  • Pharmaceutical
  • Other

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report